Table 3.
Molar ratio of added CYP2E1 to P450 present in HLM | CYP2E1 content, nmol/mg protein | p-Nitrophenol | Chlorzoxazone | |||
---|---|---|---|---|---|---|
S50, μMa | Na | Vmax, min−1 | KM, μM | Vmax, min−1 | ||
0 | 0.028 | 39 ± 17 | 1.3 ±0.2 | 6.3 ± 3.6 | 54 ± 16 | 12 ± 3 |
0.25 | 0.13 | 43 ± 7 | 1.3 ±0.4 | 12 ±6 | 79 ±29 | 42 ± 11 |
0.5 | 0.23 | 37 ± 11 | 1.6 ±0.3 | 29 ± 13 | 54 ± 4.4 | 42 ±4 |
0.75 | 0.32 | 81 ± 11 | 1.7 ±0.2 | 26 ±8 | 84 ± 13 | 105 ±25 |
1 | 0.42 | 81 ± 5 | 1.2 ±0.3 | 33 ± 12 | 65 ±20 | 78 ±8 |
1.75 | 0.72 | 48 ±2 | 1.5 ±0.4 | 27 ±9 | 87 ± 18 | 54 ± 11 |
The estimates given in the table correspond to the averages of 2–4 individual measurements. The“±” values are the confidence intervals calculated for p=0.05.
S50 are N are the concentration of half-saturation with substrate and the Hill coefficient obtained from the fitting of the titration curves with the Hill equation.